EUVIMEDEUVIMED entdecken
Crossref

Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis

R Connor Chick iD, Patrick W Underwood iD, Robert W Krell iD, Elizabeth L Barbera iD, Ryan Heslin, Alex C Kim iD, Jordan M Cloyd iD, Joal D Beane iD, Timothy M Pawlik iD

Military Medicine · 2025

DOI: 10.1093/milmed/usaf465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Military Medicine, 2025. Verfasst von R Connor Chick und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Military Personnel. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma outcomes are influenced by sociodemographic factors, including health insurance. Military beneficiaries, which include servicemembers, veterans, and their families, are often treated in civilian settings with TRICARE or Veterans Affairs acting as an insurance payor. We sought to examine outcomes among military and veteran beneficiaries with localized pancreatic cancer treated in civilian hospitals using the National Cancer Database. Materials and Methods Patients age <65 with stage I-III PDAC from 2010 to 2020 with private or other government insurance were included. Stage-stratified overall survival was analyzed using the Kaplan-Meier and multivariate Cox proportional hazards model. Logistic regression models were used to examine receipt of therapy and postoperative mortality. Survival analysis was examined after propensity score matching.

Results

Among 21,691 patients meeting inclusion criteria, 781 had other government insurance. Military beneficiaries were more likely than privately insured patients to be male and Black, and to live in low-income and rural areas. They traveled further for care and started treatment later. Furthermore, military beneficiaries were less likely to receive chemotherapy and undergo surgery. After adjusting for clinicopathologic factors, postoperative mortality was higher for military beneficiaries at 30 days (odds ratio 3.51, 95% confidence interval 1.70-7.27) and 90 days (odds ratio 3.36, 95% confidence interval 1.89-5.96). Median overall survival for privately insured patients was 18.5 months versus 14.7 for military (P < .001). Military insurance remained independently associated with worse overall survival (hazard ratio 1.15, 95% CI 1.03-1.29; P = .015). After propensity score matching, stage-stratified overall survival remained inferior for military beneficiaries (P = .004).

Conclusions

Among patients with localized pancreatic cancer, military beneficiaries were less likely to receive cancer treatment, had worse postoperative mortality, and experienced worse risk-adjusted overall survival versus individuals with private insurance. Further research is needed to investigate potential disparities in access to care and treatment outcomes among military beneficiaries and to evaluate policies aimed at closing this gap.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMilitary PersonnelHumansMaleFemaleMiddle AgedUnited StatesDatabases, FactualAdultPropensity ScoreProportional Hazards ModelsSurvival AnalysisLogistic ModelsKaplan-Meier Estimate

Autor:innen und Institutionen

  • Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH 43210, United States.
  • Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, United States.
  • Department of Surgery, Brooke Army Medical Center, San Antonio, TX 78240, United States.
  • Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.

ORCID-Profile: R Connor Chick, Patrick W Underwood, Robert W Krell, Elizabeth L Barbera, Alex C Kim, Jordan M Cloyd, Joal D Beane, Timothy M Pawlik

Zitieren

APA

Chick, R. C., Underwood, P. W., Krell, R. W., Barbera, E. L., Heslin, R., Kim, A. C., Cloyd, J. M., Beane, J. D., & Pawlik, T. M. (2025). Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis. Military Medicine. https://doi.org/10.1093/milmed/usaf465

Vancouver

Chick RC, Underwood PW, Krell RW, Barbera EL, Heslin R, Kim AC, et al. Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis. Military Medicine. 2025. doi:10.1093/milmed/usaf465

BibTeX
@article{Chick2025,
  author = {Chick, R Connor and Underwood, Patrick W and Krell, Robert W and Barbera, Elizabeth L and Heslin, Ryan and Kim, Alex C and Cloyd, Jordan M and Beane, Joal D and Pawlik, Timothy M},
  title = {Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis},
  journal = {Military Medicine},
  year = {2025},
  doi = {10.1093/milmed/usaf465}
}
Kostenlos starten →